Information Box Group
PAIN+ CPN Learn More
PainPLUS CPN
Principal Investigator
Alfonso Iorio
Aim
The aim of this Michael G. DeGroote Institute for Pain Research and Care (IPRC) supported project is to develop and maintain an evidence-based information service for health care practitioners engaged in the management of acute and chronic pain, in collaboration with the PainHQ website. In addition to including original and systematic review articles of relevance to all aspects of clinical pain care, the service provides dedicated streaming of neuropathic and post-stroke central neuropathic pain data.
PainHQ
DeGroote PainHQ
To serve as an online resource for individuals living with neuropathic pain. PainHQ provides access to a range of evidence-based resources, curated by the experts, rated by the public and supporting over two million Canadians living with neuropathy. The range of resources provided is, in part, what makes PainHQ unique. Personal stories, e-learning videos, webinars and expert blogs make up part of the site’s diverse offerings. The goal is to educate on neuropathic pain and to help make the condition more accessible to the general public. Building on McMaster’s strengths in evidence-based medicine, health education and e-learning, PainHQ is an innovative and sustainable resource for patient-centred care.
PAIN STOP Learn More
PAIN STOP: Preventing pain with Nmda antagonists-Steroids in Thoracoscopic LObectomy Procedures
Principal Investigator
Harsha Shanthanna and PJ Devereaux
Study Updates
- Our target recruitment of 24 patients at St Joseph’s Hospital, Hamilton was achieved in February 2018.
- As there was a significant procedural delay involving the ethics board at the Cleveland Clinic site, USA, the recruitment was initiated in April 2018.
SMArtVIEW Learn More
TecHnology-Enabled remote monitoring and Self-MAnagemenT —VIsion for patient EmpoWerment following Cardiac and VasculaR surgery. (THE SMArTVIEW, CoVeRed)
Principal Investigator
Dr. Michael McGillion
Partnerships
Philips Healthcare (Canada and UK); QoC Health Inc; XAHIVE; ThoughtWire; Coventry University; Cloud DX; Argyle Public Relationships; Hamilton Health Sciences; Ontario Telemedicine Network; Liverpool Heart and Chest Hospital
HIP ATTACK Trial
Chronic Pain Sub-Study in HIP ATTACK (HIP fracture Accelerated surgical TreaTment and Care) Trial
Principal Investigator
Harsha Shanthanna and PJ Devereaux
Aim
The HIP ATTACK study is a multicentre, international, parallel group randomized controlled trial of patients looking at the effects of accelerated surgical repair (within six hours of diagnosis) versus standard care (i.e., surgery usually >24 hours after diagnosis). The original trial included 1,200 patients. However, the sample size was revised in 2017 for 3,000 patients with all-cause mortality being the primary outcome at 90 days after surgery.
FORESITE-VISION Learn More
FORESITE-VISION: ‘Further Observation for chronic pain and poor functional recovery Risk Factor Examination at selected SITEs (FORESITE), a study in partnership with The Vascular events In Surgery patients cOhort evaluatioN – cardiac Surgery (VISION Cardiac Surgery)
Principal Investigator
McGillion, M., Busse, JW.
Aim
Funded by the CIHR and HAHSO, the specific objectives of FORESITE VISION are to examine the influence of cognitive factors, namely, pain-related beliefs and gender- based pain expectations, on the following outcomes up to one year following cardiac surgery: the development of CPSP, functional status and patient- level cost of illness.
Prevalence and Risk Factors associated with persistent use of opioids after Surgery - A Meta-Analysis.
Principal Investigator
Jason Busse/Yasir Rehman
Aim
To conduct and meta-analysis and systematic review to explore the prevalence and risk factors associated with the prolonged opioid use after surgery.
Effect of Cannabinoid on PPSP after TKA Learn More
The effect of cannabinoids vs. placebo on persistent post-surgical pain following total knee arthroplasty: A multicenter, randomized pilot trial
Principal Investigator
Jason Busse
Aim
The goal of the proposed pilot trial is to establish the feasibility of a larger trial by successfully recruiting 40 patients at two centres over a six-month period and demonstrating adherence to our study protocol.
Chronic Pain Network Learn More
Principal Investigator
Norm Buckley
Aim
The Chronic Pain Network (CPN), funded through the Strategy for Patient Oriented Research (SPOR) and matching funds from Network partners, is one of five addressing chronic disease. Reporting for the award began January 2016 and was originally set to conclude March 2021. Due to COVID-19, the Network was extended to 2022, with a call for an opportunity for renewal presented in the fall of 2021.